{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T20:38:43Z","timestamp":1775162323339,"version":"3.50.1"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,11,20]],"date-time":"2019-11-20T00:00:00Z","timestamp":1574208000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,11,20]],"date-time":"2019-11-20T00:00:00Z","timestamp":1574208000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003360","name":"Ligue Genevoise Contre le Cancer","doi-asserted-by":"publisher","award":["ME10206"],"award-info":[{"award-number":["ME10206"]}],"id":[{"id":"10.13039\/501100003360","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Nuovo Soldati"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Predicting the risk of liver metastasis can have important prognostic and therapeutic implications, given the availability of liver-directed therapy. Uveal melanoma has a striking predisposition for liver metastasis despite the absence of anatomical proximity. Understanding its biology may uncover factors promoting liver metastasis in other malignancies. We quantified gene expression by RNAseq in 76 uveal melanomas and combined with public data in a meta-analysis of 196 patients. The meta-analysis of uveal melanoma gene expression identified 63 genes which remained prognostic after adjustment for chromosome 3 status. Two genes, <jats:italic>PTP4A3<\/jats:italic> and <jats:italic>JPH1<\/jats:italic>, were selected by L1-penalized regression and combined in a prognostic score. The score predicted liver-specific relapse in a public pan-cancer dataset and in two public colorectal cancer datasets. The score varied between colorectal consensus molecular subtypes (CMS), as did the risk of liver relapse, which was lowest in CMS1. Additional prospective validation was done by real-time PCR in 463 breast cancer patients. The score was significantly correlated with liver relapse in hormone receptor positive tumors. In conclusion, the expression of <jats:italic>PTP4A3<\/jats:italic> and <jats:italic>JPH1<\/jats:italic> correlates with risk of liver metastasis in colorectal cancer and breast cancer. The underlying biological mechanism is an interesting area for further research.<\/jats:p>","DOI":"10.1038\/s41598-019-52841-y","type":"journal-article","created":{"date-parts":[[2019,11,20]],"date-time":"2019-11-20T11:04:02Z","timestamp":1574247842000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Prospective validation in epithelial tumors of a gene expression predictor of liver metastasis derived from uveal melanoma"],"prefix":"10.1038","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3613-6682","authenticated-orcid":false,"given":"Petros","family":"Tsantoulis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7631-3263","authenticated-orcid":false,"given":"Mauro","family":"Delorenzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ivan","family":"Bi\u00e8che","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sophie","family":"Vacher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pascale","family":"Mariani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nathalie","family":"Cassoux","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6267-2353","authenticated-orcid":false,"given":"Alexandre","family":"Houy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8100-2272","authenticated-orcid":false,"given":"Marc-Henri","family":"Stern","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sergio","family":"Roman-Roman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierre-Yves","family":"Dietrich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arnaud","family":"Roth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wulfran","family":"Cacheux","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,11,20]]},"reference":[{"key":"52841_CR1","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1001\/archopht.119.5.670","volume":"119","author":"The Collaborative Ocular Melanoma Study","year":"2001","unstructured":"The Collaborative Ocular Melanoma Study. Assessment of Metastatic Disease Status at Death in 435 Patients With Large Choroidal Melanoma in the Collaborative Ocular Melanoma Study (COMS). Arch. Ophthalmol. 119, 670 (2001).","journal-title":"Arch. Ophthalmol."},{"key":"52841_CR2","doi-asserted-by":"publisher","first-page":"4575","DOI":"10.1200\/JCO.2007.11.0833","volume":"25","author":"JS Tomlinson","year":"2007","unstructured":"Tomlinson, J. S. et al. Actual 10-Year Survival After Resection of Colorectal Liver Metastases Defines Cure. J. Clin. Oncol. 25, 4575\u20134580 (2007).","journal-title":"J. Clin. Oncol."},{"key":"52841_CR3","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1093\/annonc\/mdw235","volume":"27","author":"E Van Cutsem","year":"2016","unstructured":"Van Cutsem, E. et al. ESMO consensus guidelines for the management of patients with metastatic colorectal cancer. Ann. Oncol. 27, 1386\u20131422 (2016).","journal-title":"Ann. Oncol."},{"key":"52841_CR4","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1259\/bjr\/78268814","volume":"84","author":"AAJM Van Tilborg","year":"2011","unstructured":"Van Tilborg, A. A. J. M. et al. Long-term results of radiofrequency ablation for unresectable colorectal liver metastases: a potentially curative intervention. Br. J. Radiol. 84, 556\u2013565 (2011).","journal-title":"Br. J. Radiol."},{"key":"52841_CR5","doi-asserted-by":"publisher","first-page":"1938","DOI":"10.1200\/JCO.2016.71.8346","volume":"35","author":"B Groot Koerkamp","year":"2017","unstructured":"Groot Koerkamp, B. et al. Perioperative Hepatic Arterial Infusion Pump Chemotherapy Is Associated With Longer Survival After Resection of Colorectal Liver Metastases: A Propensity Score Analysis. J. Clin. Oncol. 35, 1938\u20131944 (2017).","journal-title":"J. Clin. Oncol."},{"key":"52841_CR6","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1126\/science.1194472","volume":"330","author":"JW Harbour","year":"2010","unstructured":"Harbour, J. W. et al. Frequent mutation of BAP1 in metastasizing uveal melanomas. Science 330, 1410\u20133 (2010).","journal-title":"Science"},{"key":"52841_CR7","doi-asserted-by":"publisher","first-page":"3259","DOI":"10.1158\/1078-0432.CCR-12-3886","volume":"19","author":"AA Hakimi","year":"2013","unstructured":"Hakimi, A. A. et al. Adverse Outcomes in Clear Cell Renal Cell Carcinoma with Mutations of 3p21 Epigenetic Regulators BAP1 and SETD2: A Report by MSKCC and the KIRC TCGA Research Network. Clin. Cancer Res. 19, 3259\u20133267 (2013).","journal-title":"Clin. Cancer Res."},{"key":"52841_CR8","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1038\/modpathol.2016.188","volume":"30","author":"NM Joseph","year":"2017","unstructured":"Joseph, N. M. et al. Genomic profiling of malignant peritoneal mesothelioma reveals recurrent alterations in epigenetic regulatory genes BAP1, SETD2, and DDX3X. Mod. Pathol. 30, 246\u2013254 (2017).","journal-title":"Mod. Pathol."},{"key":"52841_CR9","doi-asserted-by":"publisher","first-page":"556","DOI":"10.21037\/jgo.2016.03.05","volume":"7","author":"HO Al-Shamsi","year":"2016","unstructured":"Al-Shamsi, H. O. et al. BRCA-associated protein 1 mutant cholangiocarcinoma: an aggressive disease subtype. J. Gastrointest. Oncol. 7, 556\u2013561 (2016).","journal-title":"J. Gastrointest. Oncol."},{"key":"52841_CR10","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1016\/j.ajhg.2016.09.008","volume":"99","author":"B Royer-Bertrand","year":"2016","unstructured":"Royer-Bertrand, B. et al. Comprehensive Genetic Landscape of Uveal Melanoma by Whole-Genome Sequencing. Am. J. Hum. Genet. 99, 1190\u20131198 (2016).","journal-title":"Am. J. Hum. Genet."},{"key":"52841_CR11","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1136\/bjophthalmol-2013-303867","volume":"98","author":"N Cassoux","year":"2014","unstructured":"Cassoux, N. et al. Genome-wide profiling is a clinically relevant and affordable prognostic test in posterior uveal melanoma. Br. J. Ophthalmol. 98, 769\u2013774 (2014).","journal-title":"Br. J. Ophthalmol."},{"key":"52841_CR12","doi-asserted-by":"publisher","first-page":"3048","DOI":"10.1167\/iovs.08-3165","volume":"50","author":"B Damato","year":"2009","unstructured":"Damato, B. et al. Multiplex ligation-dependent probe amplification of uveal melanoma: correlation with metastatic death. Invest. Ophthalmol. Vis. Sci. 50, 3048\u201355 (2009).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"52841_CR13","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1158\/0008-5472.CAN-10-0605","volume":"71","author":"C Laurent","year":"2011","unstructured":"Laurent, C. et al. High PTP4A3 phosphatase expression correlates with metastatic risk in uveal melanoma patients. Cancer Res. 71, 666\u201374 (2011).","journal-title":"Cancer Res."},{"key":"52841_CR14","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms6457","volume":"5","author":"JC Haan","year":"2014","unstructured":"Haan, J. C. et al. Genomic landscape of metastatic colorectal cancer. Nat. Commun. 5, 5457 (2014).","journal-title":"Nat. Commun."},{"key":"52841_CR15","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1038\/nature13480","volume":"513","author":"AJ Bass","year":"2014","unstructured":"Bass, A. J. et al. Comprehensive molecular characterization of gastric adenocarcinoma. Nature 513, 202\u20139 (2014).","journal-title":"Nature"},{"key":"52841_CR16","doi-asserted-by":"publisher","first-page":"e70790","DOI":"10.1371\/journal.pone.0070790","volume":"8","author":"LC Walker","year":"2013","unstructured":"Walker, L. C. et al. Dual-Color Fluorescence In Situ Hybridization Reveals an Association of Chromosome 8q22 but Not 8p21 Imbalance with High Grade Invasive Breast Carcinoma. PLoS One 8, e70790 (2013).","journal-title":"PLoS One"},{"key":"52841_CR17","doi-asserted-by":"publisher","first-page":"7205","DOI":"10.1158\/0008-5472.CAN-04-1750","volume":"64","author":"MD Onken","year":"2004","unstructured":"Onken, M. D., Worley, L. A., Ehlers, J. P. & Harbour, J. W. Gene expression profiling in uveal melanoma reveals two molecular classes and predicts metastatic death. Cancer Res. 64, 7205\u20139 (2004).","journal-title":"Cancer Res."},{"key":"52841_CR18","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.ccell.2017.07.003","volume":"32","author":"AG Robertson","year":"2017","unstructured":"Robertson, A. G. et al. Integrative Analysis Identifies Four Molecular and Clinical Subsets in Uveal Melanoma. Cancer Cell 32, 204\u2013220.e15 (2017).","journal-title":"Cancer Cell"},{"key":"52841_CR19","doi-asserted-by":"publisher","first-page":"461","DOI":"10.2353\/jmoldx.2010.090220","volume":"12","author":"MD Onken","year":"2010","unstructured":"Onken, M. D., Worley, L. A., Tuscan, M. D. & Harbour, J. W. An Accurate, Clinically Feasible Multi-Gene Expression Assay for Predicting Metastasis in Uveal Melanoma. J. Mol. Diagnostics 12, 461\u2013468 (2010).","journal-title":"J. Mol. Diagnostics"},{"key":"52841_CR20","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.1002\/cncr.21778","volume":"106","author":"KR Hess","year":"2006","unstructured":"Hess, K. R. et al. Metastatic patterns in adenocarcinoma. Cancer 106, 1624\u20131633 (2006).","journal-title":"Cancer"},{"key":"52841_CR21","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1038\/nrc2622","volume":"9","author":"DX Nguyen","year":"2009","unstructured":"Nguyen, D. X., Bos, P. D. & Massagu\u00e9, J. Metastasis: from dissemination to organ-specific colonization. Nat. Rev. Cancer 9, 274\u2013284 (2009).","journal-title":"Nat. Rev. Cancer"},{"key":"52841_CR22","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1038\/ng1060","volume":"33","author":"S Ramaswamy","year":"2003","unstructured":"Ramaswamy, S., Ross, K. N., Lander, E. S. & Golub, T. R. A molecular signature of metastasis in primary solid tumors. Nat. Genet. 33, 49\u201354 (2003).","journal-title":"Nat. Genet."},{"key":"52841_CR23","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.trecan.2015.07.009","volume":"1","author":"AC Obenauf","year":"2015","unstructured":"Obenauf, A. C. & Massagu\u00e9, J. Surviving at a distance: organ specific metastasis. Trends in cancer 1, 76\u201391 (2015).","journal-title":"Trends in cancer"},{"key":"52841_CR24","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1002\/ijc.20883","volume":"115","author":"A D\u2019Arrigo","year":"2005","unstructured":"D\u2019Arrigo, A. et al. Metastatic transcriptional pattern revealed by gene expression profiling in primary colorectal carcinoma. Int. J. Cancer 115, 256\u2013262 (2005).","journal-title":"Int. J. Cancer"},{"key":"52841_CR25","doi-asserted-by":"publisher","first-page":"2005","DOI":"10.1002\/ijc.22975","volume":"121","author":"DH Ki","year":"2007","unstructured":"Ki, D. H. et al. Whole genome analysis for liver metastasis gene signatures in colorectal cancer. Int. J. Cancer 121, 2005\u20132012 (2007).","journal-title":"Int. J. Cancer"},{"key":"52841_CR26","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1007\/s10549-011-1619-7","volume":"132","author":"JC Harrell","year":"2012","unstructured":"Harrell, J. C. et al. Genomic analysis identifies unique signatures predictive of brain, lung, and liver relapse. Breast Cancer Res. Treat. 132, 523\u2013535 (2012).","journal-title":"Breast Cancer Res. Treat."},{"issue":"10","key":"52841_CR27","doi-asserted-by":"publisher","first-page":"5661","DOI":"10.1096\/fj.201701446R","volume":"32","author":"Kelley E. McQueeney","year":"2018","unstructured":"McQueeney, K. E. et al. A chemical genetics approach identifies PTP4A3 as a regulator of colon cancer cell adhesion. FASEB J. fj.201701446R, https:\/\/doi.org\/10.1096\/fj.201701446R (2018).","journal-title":"The FASEB Journal"},{"key":"52841_CR28","doi-asserted-by":"publisher","first-page":"1982","DOI":"10.1167\/iovs.15-18780","volume":"57","author":"S Maacha","year":"2016","unstructured":"Maacha, S. et al. Protein Tyrosine Phosphatase 4A3 (PTP4A3) Promotes Human Uveal Melanoma Aggressiveness Through Membrane Accumulation of Matrix Metalloproteinase 14 (MMP14). Investig. Opthalmology Vis. Sci. 57, 1982 (2016).","journal-title":"Investig. Opthalmology Vis. Sci."},{"key":"52841_CR29","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.yexcr.2017.03.012","volume":"353","author":"M Foy","year":"2017","unstructured":"Foy, M., An\u00e9zo, O., Saule, S. & Planque, N. PRL-3\/PTP4A3 phosphatase regulates integrin \u03b21 in adhesion structures during migration of human ocular melanoma cells. Exp. Cell Res. 353, 88\u201399 (2017).","journal-title":"Exp. Cell Res."},{"issue":"1","key":"52841_CR30","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s10585-015-9749-7","volume":"33","author":"N. Nakayama","year":"2015","unstructured":"Nakayama, N. et al. Genomic gain of the PRL-3 gene may represent poor prognosis of primary colorectal cancer, and associate with liver metastasis. Clin. Exp. Metastasis, https:\/\/doi.org\/10.1007\/s10585-015-9749-7 (2015).","journal-title":"Clinical & Experimental Metastasis"},{"key":"52841_CR31","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-10-662","volume":"10","author":"SC Bruin","year":"2010","unstructured":"Bruin, S. C. et al. Specific genomic aberrations in primary colorectal cancer are associated with liver metastases. BMC Cancer 10, 662 (2010).","journal-title":"BMC Cancer"},{"key":"52841_CR32","first-page":"11","volume":"6","author":"H Takeshima","year":"2000","unstructured":"Takeshima, H. et al. Junctophilins. Mol. Cell 6, 11\u201322 (2000).","journal-title":"Mol. Cell"},{"key":"52841_CR33","doi-asserted-by":"publisher","DOI":"10.1038\/srep44564","volume":"7","author":"P Fagone","year":"2017","unstructured":"Fagone, P. et al. Identification of novel chemotherapeutic strategies for metastatic uveal melanoma. Sci. Rep. 7, 44564 (2017).","journal-title":"Sci. Rep."},{"key":"52841_CR34","doi-asserted-by":"publisher","first-page":"e42669","DOI":"10.1371\/journal.pone.0042669","volume":"7","author":"S Badve","year":"2012","unstructured":"Badve, S. et al. Molecular Analysis of Thymoma. PLoS One 7, e42669 (2012).","journal-title":"PLoS One"},{"key":"52841_CR35","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1067\/msy.2000.103883","volume":"127","author":"M Selzner","year":"2000","unstructured":"Selzner, M., Morse, M. A., Vredenburgh, J. J., Meyers, W. C. & Clavien, P. A. Liver metastases from breast cancer: long-term survival after curative resection. Surgery 127, 383\u20139 (2000).","journal-title":"Surgery"},{"key":"52841_CR36","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1053\/ejso.1999.0778","volume":"26","author":"S-M Maksan","year":"2000","unstructured":"Maksan, S.-M., Lehnert, T., Bastert, G. & Herfarth, C. Curative liver resection for metastatic breast cancer. Eur. J. Surg. Oncol. 26, 209\u2013212 (2000).","journal-title":"Eur. J. Surg. Oncol."},{"key":"52841_CR37","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.molonc.2013.10.002","volume":"8","author":"S Kimbung","year":"2014","unstructured":"Kimbung, S. et al. Claudin-2 is an independent negative prognostic factor in breast cancer and specifically predicts early liver recurrences. Mol. Oncol. 8, 119\u2013128 (2014).","journal-title":"Mol. Oncol."},{"key":"52841_CR38","doi-asserted-by":"publisher","first-page":"2119","DOI":"10.1016\/j.ejca.2010.04.019","volume":"46","author":"T Watanabe","year":"2010","unstructured":"Watanabe, T. et al. Prediction of liver metastasis after colorectal cancer using reverse transcription-polymerase chain reaction analysis of 10 genes. Eur. J. Cancer 46, 2119\u20132126 (2010).","journal-title":"Eur. J. Cancer"},{"key":"52841_CR39","doi-asserted-by":"crossref","first-page":"D991","DOI":"10.1093\/nar\/gks1193","volume":"41","author":"T Barrett","year":"2013","unstructured":"Barrett, T. et al. NCBI GEO: archive for functional genomics data sets\u2013update. Nucleic Acids Res. 41, D991\u2013D995 (2013).","journal-title":"Nucleic Acids Res."},{"key":"52841_CR40","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1002\/path.4212","volume":"231","author":"E Budinska","year":"2013","unstructured":"Budinska, E. et al. Gene expression patterns unveil a new level of molecular heterogeneity in colorectal cancer. J. Pathol. 231, 63\u201376 (2013).","journal-title":"J. Pathol."},{"key":"52841_CR41","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1007\/s12094-011-0676-z","volume":"13","author":"T Watanabe","year":"2011","unstructured":"Watanabe, T. et al. Gene expression signature and response to the use of leucovorin, fluorouracil and oxaliplatin in colorectal cancer patients. Clin. Transl. Oncol. 13, 419\u2013425 (2011).","journal-title":"Clin. Transl. Oncol."},{"key":"52841_CR42","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/j.cell.2018.02.052","volume":"173","author":"J Liu","year":"2018","unstructured":"Liu, J. et al. An Integrated TCGA Pan-Cancer Clinical Data Resource to Drive High-Quality Survival Outcome Analytics. Cell 173, 400\u2013416.e11 (2018).","journal-title":"Cell"},{"key":"52841_CR43","first-page":"15","volume-title":"Bioinformatics","author":"A Dobin","year":"2013","unstructured":"Dobin, A. et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics 29, 15\u201321 (2013)."},{"key":"52841_CR44","doi-asserted-by":"publisher","first-page":"1530","DOI":"10.1093\/bioinformatics\/bts196","volume":"28","author":"DS DeLuca","year":"2012","unstructured":"DeLuca, D. S. et al. RNA-SeQC: RNA-seq metrics for quality control and process optimization. Bioinformatics 28, 1530\u20131532 (2012).","journal-title":"Bioinformatics"},{"key":"52841_CR45","doi-asserted-by":"publisher","first-page":"4288","DOI":"10.1093\/nar\/gks042","volume":"40","author":"DJ McCarthy","year":"2012","unstructured":"McCarthy, D. J., Chen, Y. & Smyth, G. K. Differential expression analysis of multifactor RNA-Seq experiments with respect to biological variation. Nucleic Acids Res. 40, 4288\u20134297 (2012).","journal-title":"Nucleic Acids Res."},{"key":"52841_CR46","doi-asserted-by":"publisher","first-page":"8109","DOI":"10.1038\/sj.onc.1204917","volume":"20","author":"I Bi\u00e8che","year":"2001","unstructured":"Bi\u00e8che, I. et al. Quantification of estrogen receptor \u03b1 and \u03b2 expression in sporadic breast cancer. Oncogene 20, 8109\u20138115 (2001).","journal-title":"Oncogene"},{"key":"52841_CR47","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1093\/clinchem\/45.8.1148","volume":"45","author":"I Bi\u00e8che","year":"1999","unstructured":"Bi\u00e8che, I. et al. Real-time reverse transcription-PCR assay for future management of ERBB2-based clinical applications. Clin. Chem. 45, 1148\u201356 (1999).","journal-title":"Clin. Chem."},{"key":"52841_CR48","doi-asserted-by":"crossref","unstructured":"Benjamini, Y. & Hochberg, Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. R. Stat. Soc. Ser. B 289\u2013300 (1995).","DOI":"10.1111\/j.2517-6161.1995.tb02031.x"},{"key":"52841_CR49","series-title":"Statistics for Biology and Health","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4757-3294-8","volume-title":"Modeling Survival Data: Extending the Cox Model","author":"Terry M. Therneau","year":"2000","unstructured":"Therneau, T. M. & Grambsch, P. M. Modeling Survival Data: Extending the Cox Model., https:\/\/doi.org\/10.1007\/978-1-4757-3294-8 (Springer New York, 2000)."},{"key":"52841_CR50","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v036.i03","volume":"36","author":"W Viechtbauer","year":"2010","unstructured":"Viechtbauer, W. Conducting Meta-Analyses in R with the metafor Package. J. Stat. Softw. 36, 1\u201348 (2010).","journal-title":"J. Stat. Softw."},{"key":"52841_CR51","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1093\/comjnl\/26.4.354","volume":"26","author":"F Murtagh","year":"1983","unstructured":"Murtagh, F. A Survey of Recent Advances in Hierarchical Clustering Algorithms. Comput. J. 26, 354\u2013359 (1983).","journal-title":"Comput. J."},{"key":"52841_CR52","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v039.i05","volume":"39","author":"N Simon","year":"2011","unstructured":"Simon, N., Friedman, J., Hastie, T. & Tibshirani, R. Regularization Paths for Cox\u2019s Proportional Hazards Model via Coordinate Descent. J. Stat. Softw. 39, 1\u201313 (2011).","journal-title":"J. Stat. Softw."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-52841-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-52841-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-52841-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T16:07:59Z","timestamp":1671293279000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-52841-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,20]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["52841"],"URL":"https:\/\/doi.org\/10.1038\/s41598-019-52841-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,20]]},"assertion":[{"value":"19 March 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 October 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 November 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"17178"}}